These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3947714)

  • 1. Superoxide dismutase activity in fibroblasts from patients with schizophrenia.
    Cohen MR; Sailer V; McAmis B; Jenkins P
    Biol Psychiatry; 1986 Mar; 21(3):322-4. PubMed ID: 3947714
    [No Abstract]   [Full Text] [Related]  

  • 2. MAT kinetics in affective disorders and schizophrenia. An account.
    Tolbert LC
    Ala J Med Sci; 1988 Jul; 25(3):291-6. PubMed ID: 3177804
    [No Abstract]   [Full Text] [Related]  

  • 3. Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients.
    Abdalla DS; Monteiro HP; Oliveira JA; Bechara EJ
    Clin Chem; 1986 May; 32(5):805-7. PubMed ID: 2870827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The preliminary study of monoamine oxidase activity in platelets in patients with schizophrenia and affective disorder].
    Lin Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):325-7, 382. PubMed ID: 1304991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated platelet monoamine oxidase activity in patients wth nonendogenous depression.
    White K; Shih J; Fong T; Young H; Gelfand R; Boyd J; Simpson G; Sloane RB
    Am J Psychiatry; 1980 Oct; 137(10):1258-9. PubMed ID: 7416279
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced antioxidant defense systems in schizophrenia and bipolar I disorder.
    Raffa M; Barhoumi S; Atig F; Fendri C; Kerkeni A; Mechri A
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):371-5. PubMed ID: 22841966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-6-phosphate dehydrogenase deficiency in a psychiatric population: a preliminary study.
    Nasr SJ; Altman E; Pscheidt G; Meltzer HY
    Biol Psychiatry; 1982 Aug; 17(8):925-8. PubMed ID: 7115841
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreased activity of erythrocyte membrane ATPases in depression and schizophrenia.
    Rybakowski JK; Lehmann W
    Neuropsychobiology; 1994; 30(1):11-4. PubMed ID: 7969852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte sodium pump activity in bipolar affective disorder and other psychiatric disorders.
    Hokin-Neaverson M; Jefferson JW
    Neuropsychobiology; 1989; 22(1):1-7. PubMed ID: 2561681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal activity of nucleoside phosphorylase, superoxide dismutase and catalase in skin fibroblasts cultured from ataxia-telangiectasia patients.
    Abeliovich D; Cohen MM
    Isr J Med Sci; 1978 Feb; 14(2):284-7. PubMed ID: 418025
    [No Abstract]   [Full Text] [Related]  

  • 11. Aryl sulfatase A deficiency in psychiatric and neurologic patients.
    Herska M; Moscovich DG; Kalian M; Gottlieb D; Bach G
    Am J Med Genet; 1987 Mar; 26(3):629-35. PubMed ID: 2882680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-carbon metabolism disturbances in affective disorders. A preliminary report.
    Alarcon RD; Tolbert LC; Monti JA; Morere DA; Walter-Ryan WG; Kemp B; Smythies JR
    J Affect Disord; 1985 Nov; 9(3):297-301. PubMed ID: 2934462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum dopamine-beta-hydroxylase activity in clinical subtypes of depression.
    Sapru MK; Rao BS; Channabasavanna SM
    Acta Psychiatr Scand; 1989 Nov; 80(5):474-8. PubMed ID: 2596346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental changes in the superoxide dismutase activity of human skin fibroblasts are maintained in vitro and are not caused by oxygen.
    Allen RG; Balin AK
    J Clin Invest; 1988 Aug; 82(2):731-4. PubMed ID: 3403724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia.
    Wyatt RJ; Murphy DL
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():289-97. PubMed ID: 769116
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder.
    Kuloglu M; Ustundag B; Atmaca M; Canatan H; Tezcan AE; Cinkilinc N
    Cell Biochem Funct; 2002 Jun; 20(2):171-5. PubMed ID: 11979513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The activity of true cholinesterase in depressive states of different origin].
    Kodinets LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(6):895-99. PubMed ID: 4454916
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel protein isoform of catechol O-methyltransferase (COMT): brain expression analysis in schizophrenia and bipolar disorder and effect of Val158Met genotype.
    Tunbridge EM; Weinberger DR; Harrison PJ
    Mol Psychiatry; 2006 Feb; 11(2):116-7. PubMed ID: 16247488
    [No Abstract]   [Full Text] [Related]  

  • 19. Postmortem parietal cortex TPH2 expression is not altered in schizophrenic, unipolar-depressed, and bipolar patients vs control subjects.
    Shamir A; Shaltiel G; Levi I; Belmaker RH; Agam G
    J Mol Neurosci; 2005; 26(1):33-7. PubMed ID: 15968084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAO-B activity in depression and anxiety disorders.
    Sofuoğlu S; Doğan P; Besim T; Baştürk M; Tanrikulu G
    Biol Psychiatry; 1992 Mar; 31(6):634-8. PubMed ID: 1581446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.